Palynziq (Pegvaliase)

Pegvaliase, the active ingredient in Palynziq, is a enzyme substitution therapy presented as a solution for subcutaneous injection use. It is indicated for the management of phenylalanine metabolism in adults with hereditary phenylketonuria (PKU). GNH USA supplies Palynziq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Palynziq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Palynziq is a pegylated enzyme therapy that acts on the phenylalanine metabolic pathway ​​ ​  ​  .

- Phenylketonuria (PKU):  Provides         ...  ....   ...   …  .... … … … … … … -  …  …  ...  ...  ...